Macrovision Receiving Attention for Bone Densitometer ‘Osteoprima’

WONJU--(Korea Newswire)--As the population is rapidly aging, the number of patients with osteoporosis, one the representative aging-related diseases, is increasing.

Accordingly, the need for the medical device for prevention and treatment of osteoporosis is emerging, and the medical device specializing company Macrovision(CEO: Ji-Hyun Yoon, www.emacro.kr) is receiving attention for its bone densitometer ‘Osteoprima.’

‘Osteoprima’ is the measuring instrument dedicated for AP-Spine & Femur (Forearm option) for prevention and treatment inspection of osteoporosis, and is the bed-type device of DEXA type where future fracture risk and trending inspection are available.

In case of Spine & Femur, it accurately scans the area with 40% or greater of trabecular bone so that the estrogen and treatment reaction can be sensitively and accurately tested, and configured measurement reflecting the individuality of the patient is available. It features not only soft tissue correction but also accurate bone edge measurement, and the K-edge filter with pencil beam method with smaller exposure.

After handling, the result per patient can be monitored, and the compact, stylish and ergonomic design and powerful and rich diagnostic software allows for scanning the AP-Spine & Femur region in interest within a short period of time.

Also, it can be operated easily and conveniently with mouse controls in the Windows XP environment familiar to the operator, and the automatic analysis of ROI and manual analysis of region in doubt are available so that various interpretations are provided.

Macrovision CEO Ji-Hyun Yoon said that “’Osteoprima’ is a product developed after long research and effort, providing a convenient system for the medical staff and the best medical service for the patients” and that “we will continue active progress not only domestically but also in overseas advancement.”

Currently, there are 500 or so units of ‘Osteoprima’ in operation at domestic local hospitals and general hospitals, being recognized for its significant clinical quality with economical costs. (Inquiries: +82-70-7019-3345, info@emacro.kr)

This is a news release distributed by Korea Newswire on behalf of this company.